Dialogue Health Technologies Inc. – Trademark Portfolio
Entity Type: 03
Dialogue Health Technologies Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 7 Nice Classification classes.
390 Notre-Dame West
Suite 200 Montréal QUEBEC H2Y 1T9
Showing of trademarks Trademarks
Trademark Classifications
Dialogue Health Technologies Inc.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Dialogue Health Technologies Inc. have?
Dialogue Health Technologies Inc. has 1 U.S. trademark filed with the USPTO.
What trademark classes does Dialogue Health Technologies Inc. file in?
Dialogue Health Technologies Inc. files trademarks across 7 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What is Dialogue Health Technologies Inc.'s trademark registration success rate?
Dialogue Health Technologies Inc. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.